Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
grade B 27.7 1.09% 0.30
HZNP closed up 1.09 percent on Monday, October 21, 2019, on 1.39 times normal volume.

Earnings due: Nov 6

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical HZNP trend table...

Date Alert Name Type % Chg
180 Bullish Setup Bullish Swing Setup 0.00%
Cup with Handle Other 0.00%
Stochastic Sell Signal Bearish 1.09%
Slingshot Bullish Bullish Swing Setup 1.09%
Cup with Handle Other 1.09%
Upper Bollinger Band Walk Strength 1.09%
Overbought Stochastic Strength 1.09%
Cup with Handle Other -2.74%
Upper Bollinger Band Walk Strength -2.74%
Overbought Stochastic Strength -2.74%

Older signals for HZNP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.
Medicine Health Pharmaceutical Pain Autoimmune Diseases Rheumatoid Arthritis Osteoarthritis Asthma Inflammatory Diseases Arthritis Chronic Obstructive Pulmonary Disease Rheumatology Psoriatic Arthritis
Is HZNP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.44
52 Week Low 16.56
Average Volume 1,125,951
200-Day Moving Average 25.2119
50-Day Moving Average 26.9969
20-Day Moving Average 27.0433
10-Day Moving Average 27.3605
Average True Range 0.8435
ADX 15.03
+DI 25.5406
-DI 23.6636
Chandelier Exit (Long, 3 ATRs ) 26.7595
Chandelier Exit (Short, 3 ATRs ) 27.5655
Upper Bollinger Band 28.7271
Lower Bollinger Band 25.3595
Percent B (%b) 0.7
BandWidth 12.452622
MACD Line 0.3249
MACD Signal Line 0.1908
MACD Histogram 0.1341
Fundamentals Value
Market Cap 4.52 Billion
Num Shares 163 Million
EPS -2.70
Price-to-Earnings (P/E) Ratio -10.26
Price-to-Sales 2.16
Price-to-Book 2.16
PEG Ratio 0.99
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.77
Resistance 3 (R3) 28.68 28.24 28.59
Resistance 2 (R2) 28.24 27.97 28.28 28.53
Resistance 1 (R1) 27.97 27.80 28.11 28.06 28.47
Pivot Point 27.53 27.53 27.60 27.57 27.53
Support 1 (S1) 27.26 27.26 27.40 27.35 26.93
Support 2 (S2) 26.82 27.09 26.86 26.87
Support 3 (S3) 26.55 26.82 26.81
Support 4 (S4) 26.64